DNase II digests the chromosomal
DNA in macrophages after apoptotic cells and nuclei from erythroid precursors are engulfed. The
DNase II-null mice develop a
polyarthritis that resembles
rheumatoid arthritis. Here, we showed that when bone marrow cells from the
DNase II-deficient mice were transferred to the wild-type mice, they developed
arthritis. A deficiency of Rag2 or a lack of lymphocytes accelerated
arthritis of the
DNase II-null mice, suggesting that the
DNase II(-/-) macrophages were responsible for triggering
arthritis, and their lymphocytes worked protectively. A high level of TNFα, IL-1β, and
IL-6 was found in the affected joints of the
DNase II-null mice, suggesting an inflammatory-skewed
cytokine storm was established in the joints. A lack of TNFα, IL-1β, or
IL-6 gene blocked the expression of the other
cytokine genes as well and inhibited the development of
arthritis. Neutralization of TNFα, IL-1β, or
IL-6 had a
therapeutic effect on the developed
arthritis of the
DNase II-null mice, indicating that the
cytokine storm was essential for the maintenance of
arthritis in the
DNase II-deficient mice.
Methotrexate, an
antimetabolite that is often used to treat patients with
rheumatoid arthritis, had a
therapeutic effect with the
DNase II-null mice. These properties of
arthritis in the
DNase II-null mice were similar to those found in human systemic-onset
juvenile idiopathic arthritis or Still's disease, indicating that the
DNase II-null mice are a good animal model of this type of
arthritis.